The role of percutaneous transluminal coronary angioplasty in heart transplant recipients

Journal of Heart and Lung Transplantation

Volumn 19, Issue 6, 2000, Pages 557-565

  Schnetzler, Bruno ^a   Drobinski, Gerard ^a   Dorent, Richard ^a   Camproux, Anne Claude ^a   Ghossoub, Jean Jacques ^a   Thomas, Daniel ^a   Gandjbakhch, Iradj ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTICLE; CAUSE OF DEATH; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; GRAFT OCCLUSION; GRAFT REJECTION; HEART TRANSPLANTATION; HUMAN; ISCHEMIA; MALE; PRIORITY JOURNAL; RESTENOSIS; TRANSLUMINAL CORONARY ANGIOPLASTY;

ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CAUSE OF DEATH; CORONARY ANGIOGRAPHY; FEMALE; HEART TRANSPLANTATION; HUMANS; MALE; MYOCARDIAL ISCHEMIA; RECURRENCE; RETROSPECTIVE STUDIES; STENTS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0034043116     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-2498(00)00115-7     Document Type: Article

References (29)

1. Hosenpud J.D., Novick R.J., Bennett L.E., Keck B.M., Fiol B., Daily O.P. The Registry of the International Society for Heart and Lung Transplantation thirteenth Official Report-1996 . J Heart Lung Transplant. 15:1996;655-674.
2. Hoyt G., Gollin G., Billingham M., Miller D.C., Jamieson S.W. Effects of anti-platelet regimens in combination with cyclosporine on heart allograft vessel disease. J Heart Transplant. 4:1984;54-56.
3. Billingham M.E. Cardiac transplant atherosclerosis. Transplant Proc. 4:1987;9-25.
4. Copeland J.G., Butman S.M., Sethi G.K., et al. Successful coronary artery bypass grafting for high risk left main coronary artery atherosclerosis after cardiac transplantation. Ann Thorac Surg. 49:1990;06-10.
5. Schnetzler B., Pavie A., Dorent R., et al. Heart retransplantation. A 23-year single-center clinical experience. Ann Thorac Surg. 65:1998;978-983.
6. Halle A.A., DiSciascio G., Massin E., et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol. 26:1995;120-128.
7. Johnson TH, Das GS, McGinn AL, et al. Physiologic assessment of the coronary collateral circulation in tranplanted human hearts. J Heart Transplant 1994;13:840-6.
8. Christensen B.V., Meyer S.M., Icarella C.L., et al. Coronary angioplasty in heart transplant recipients a quantitative angiographic long-term follow-up study . J Heart Transplant. 13:1994;212-220.
9. Mullins P.A., Shapiro L.M., Aravot D.A., et al. Experience of percutaneous transluminal coronary angioplasty in orthotopic cardiac transplant recipients. European Heart J. 12:1991;1205-1207.
10. Sandhu J.S., Uretsky B.F., Reddy P.S., et al. Potential limitations of percutaneous transluminal coronary angioplasty in heart transplant recipients. Am J Cardiol. 69:1992;1234-1237.
11. Ryan T.J., Raxon D.P., Gunnar R.M., et al. Guidelines for percutaneous transluminal coronary angioplasty. J Am Coll Cardiol. 12:1988;529-545.
12. Moliterno DJ, Topol EJ. Clinical evaluation of restenosis. In Atherosclerosis and coronary artery disease. Fuster V, Ross R, Topol EJ. Philadelphia : Lippincott-Raven Publishers, 1996:1505-26.
13. Smart F.W., Ballantyne C.M., Cocanougher B., et al. Insensivity of noninvasive tests to detect coronary artery vasculopathy after heart transplantation. Am J Cardiol. 67:1991;243-247.
14. Derumeaux G., Redonnet M., Soyer R., Cribier A., Letac B. Assessment of the progression of cardiac allograft vasculopathy by dobutamine stress echocardiography. J Heart Lung Transplant. 17:1998;259-267.
15. Akosah K.O., Mohanty P.K. Role of dobutamine stress echocardiography in heart transplant patients. Chest. 113:1998;809-815.
16. Spes C.H., Klauss V., Mudra H., et al. Diagnostic and prognostic value of serial dobutamine stress echocardiography for noninvasive assessment of cardiac allograft vasculopathy. Circulation. 100:1999;509-515.
17. Grattan M.T., Moreno-Cabral C.E., Stames V.A., Oyer P.E., Stinson E.B., Shumway N.E. Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA. 261:1989;3561-3566.
18. McDonald K., Rector T.S., Braunlin E.A., Olivari M.T. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus. Am J Cardiol. 64:1989;359-362.
19. Everett J.P., Hershberger R.E., Norman D.J., et al. Prolonged cytomegalovirus infection with viremia is associated with development of cardiac allograft vasculopathy. J Heart Lung Transplant. 11:1992;S133-S137.
20. Wu T.C., Hruban R.H., Ambinder R.F., et al. Demonstration of cytomegalovirus nucleic acids in the coronary arteries of transplanted hearts. Am J Pathol. 140:1992;739-747.
21. Epstein S.E., Speir E., Zhou Y.F., Guetta E., Leon M., Finkel T. The role of infection in restenosis and atherosclerosis focus on cytomegalovirus . Lancet. 348:(Suppl 1):1996;13-17.
22. Thomas W, Lele S, Adler S, Goudreau E, Cowley M, Vetrovec G. Lack of evidence for a relationship between cytomegalovirus status in coronary angiographic restenosis. Circulation. 1997;96 (Suppl):I-650 (Abstract).
23. Muhlestein JB, Carlquist JF, Home BD, et al. No association between prior cytomegalovirus infection and the risks of clinical restenosis after percutaneous coronary interventions. Circulation 1997:96 (Suppl):I-650 (Abstract).
24. Carlsson J, Karl-Heinz M, Miketic S, Brom J, Ross R, Tebbe U. Prior cytomegalovirus infection and the risk of restenosis after percutaneous transluminal coronary angioplasty : results from the VERAS study. Circulation 1997:(Suppl):I-650 (Abstract).
25. Schroeder J.S., Gao S.Z., Alderman E.L., et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med. 328:1993;164-170.
26. Kobashigawa J.A., Katznelson S., Laks H., et al. Effect of pravastatin on outcomes after cardiac transplantation. N Engl J Med. 333:1995;621-627.
27. Wenke K., Meiser B., Thiery J., et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation. Circulation. 96:1997;1398-1402.
28. De Lorgeril M., Boissonat P., Mamelle, et al. Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients. Circulation. 89:1994;2590-2594.
29. Keogh A.M., Valantine H.A., Hunt S.A., et al. Impact of proximal or midvessel discrete coronary artery stenoses on survival after heart transplantation. J Heart Lung Transplant. 11:1992;892-901.